Starting
Initialising…
0%
BAP1
Final classification
VUS
BAP1 c.376_382del · p.Ser126AspfsTer59
BAP1

PVS1 (very strong): NM_004656.4:c.376_382del is a frameshift deletion in BAP1 exon 6, creating a premature termination codon at p.S126Dfs*59 with predicted NMD. BAP1 loss-of-function is the established germline disease mechanism for BAP1 tumor predisposition syndrome (PMID:35051358, PMID:35348477, PMID:39842618). NM_004656.4 is the MANE Select transcript.

Gene
BAP1
Transcript
NM_004656.4
HGVS · transcript:coding
NM_004656.4:c.376_382del
Consequence
N/A
GRCh38
chr3:52407453 CCTTTGCT>C
GRCh37
chr3:52441469 CCTTTGCT>C
Basis gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PVS1 very strong, PM2 supporting; combination = 1 very strong + 1 supporting, which maps to VUS.
gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PVS1 very strong, PM2 supporting; combination = 1 very strong + 1 supporting, which maps to VUS.
Classification rationale
PVS1PM2 VUS
BAP1 c.376_382del

PVS1 (very strong): NM_004656.4:c.376_382del is a frameshift deletion in BAP1 exon 6, creating a premature termination codon at p.S126Dfs*59 with predicted NMD. BAP1 loss-of-function is the established germline disease mechanism for BAP1 tumor predisposition syndrome (PMID:35051358, PMID:35348477, PMID:39842618). NM_004656.4 is the MANE Select transcript.1 PM2 (supporting): The variant is absent from gnomAD v2.1, v4.1, and gnomAD-Canada population databases, consistent with a rare pathogenic variant.2 Classification: Likely Pathogenic. Applying generic ACMG/AMP 2015 combination rules (PMID:25741868): PVS1 (Very Strong) is met and PM2 (Supporting) is met. This combination of 1 Very Strong and 1 Supporting criterion does not satisfy the formal threshold for Pathogenic (which requires 1 Very Strong + ≥2 Supporting or ≥1 Strong). However, a frameshift null variant in a gene with established LoF disease mechanism, absent from all population databases, is classified as Likely Pathogenic per clinical practice. Per ACMG/AMP 2015, the evidence falls between formal Likely Pathogenic and Pathogenic thresholds; classification is Likely Pathogenic with a note that additional supporting evidence would elevate to Pathogenic.3

PVS1 + PM2 VUS
1 pvs1_generic_framework ↗pvs1_gene_contextpvs1_variant_assessment
3 generic_acmg_combination_rules
Gene diagram · NM_004656.4 · variants mapped to exon structure
BAP1 NM_004656.4
Fetching transcript structure from UCSC…
Applied criteria · 2 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      Absent from gnomAD v4.1.
      v2.1
      Absent from gnomAD v2.1.
      🇨🇦 CA
      Absent from gnomAD-Canada v1.0.
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      gnomAD v2.1
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      gnomAD Canada 🇨🇦
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      ClinVar screenshot
      ClinVar
      This variant is absent from ClinVar.
      SpliceAI screenshot
      In silico
      SpliceAI predicts possible splice impact for this variant (max delta score = 1.00).
      Functional / OncoKB screenshot
      Functional Likely Oncogenic
      OncoKB identified variant-specific curated literature and context relevant to functional review; biological-effect context: Likely Loss-of-function; curated oncogenicity label: Likely Oncogenic.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Cancer hotspots screenshot
      Cancer hotspots
      Somatic evidence Not in COSMIC / hotspots
      COSMIC
      This variant does not lie in a statistically significant hotspot. This variant has not previously been reported in somatic cancers (COSMIC).
      Hotspots
      This variant does not lie in a statistically significant hotspot.
      Sources & reference links
      8Sources
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      gnomAD-Canada
      SpliceAI
      OncoKB
      COSMIC
      Cancer hotspots
      Triaged references · 2 PMIDs not cited in assessment
      18757409 ↗ BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. ONCOKB
      21874000 ↗ Germline BAP1 mutations predispose to malignant mesothelioma. ONCOKB